Related Experiment Videos

Melanostatin (NPY) inhibited electrical activity in frog melanotrophs through modulation of K+, Na+ and Ca2+ currents

J A Valentijn1, H Vaudry, W Kloas

  • 1European Institute for Peptide Research, Laboratory of Molecular Endocrinology, CNRS URA 650, UA INSERM, University of Rouen, Mont-Saint-Aignan, France.

Insights

Melanostatin, a frog peptide, alters electrical activity in melanotrophs by causing hyperpolarization and modulating ion currents. These effects, mediated by G proteins, impact action potentials and hormone release.

Area of Science:

  • Neuroendocrinology
  • Cellular electrophysiology

Background:

  • Melanostatin is an amphibian peptide homologous to mammalian neuropeptide Y (NPY).
  • It inhibits alpha-melanocyte-stimulating hormone (alpha-MSH) release from frog melanotrophs.

Purpose of the Study:

  • To investigate the effects of synthetic melanostatin on the bioelectrical activity of cultured frog melanotrophs.
  • To elucidate the ion channels and signaling pathways involved in melanostatin's action.

Main Methods:

  • Whole-cell patch-clamp technique on cultured frog melanotrophs.
  • Current-clamp and voltage-clamp recordings.
  • Application of synthetic melanostatin, guanosine-5'-O-(3-thiotriphosphate) (GTP gamma S), dopamine, and pertussis toxin.

Main Results:

  • Melanostatin induced reversible hyperpolarization and suppressed spontaneous action potentials.
  • A G protein-mediated outward potassium current was observed.
  • Melanostatin increased voltage-activated potassium currents and decreased fast sodium currents.
  • It reduced high voltage-activated N- and L-like calcium currents, an effect blocked by pertussis toxin.

Conclusions:

  • Melanostatin exerts complex electrical effects on frog melanotrophs, including hyperpolarization and modulation of voltage-gated currents.
  • G proteins mediate at least part of melanostatin's signaling pathway.
  • These actions likely contribute to the regulation of alpha-MSH release.

Related Concept Videos